Filing Details

Accession Number:
0001209191-15-045956
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-05-22 13:34:57
Reporting Period:
2015-05-20
Filing Date:
2015-05-22
Accepted Time:
2015-05-22 13:34:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1469443 Arcadia Biosciences Inc. RKDA Agricultural Chemicals (2870) 810571538
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1516392 E Darby Shupp C/O Arcadia Biosciences, Inc.
202 Cousteau Place, Suite 105
Davis CA 95618
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-05-20 1,000,000 $8.00 1,160,714 No 4 P Indirect By Moral Compass Corporation
Common Stock Acquisiton 2015-05-20 15,170,451 $0.00 16,331,165 No 4 C Indirect By Moral Compass Corporation
Common Stock Acquisiton 2015-05-20 3,847,751 $0.00 20,178,916 No 4 C Indirect By Moral Compass Corporation
Common Stock Acquisiton 2015-05-20 2,336,448 $0.00 22,515,364 No 4 C Indirect By Moral Compass Corporation
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Moral Compass Corporation
No 4 C Indirect By Moral Compass Corporation
No 4 C Indirect By Moral Compass Corporation
No 4 C Indirect By Moral Compass Corporation
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Convertible Preferred Stock Disposition 2015-05-20 60,681,805 $0.00 15,170,451 $0.00
Common Stock Series B Convertible Preferred Stock Disposition 2015-05-20 15,391,006 $0.00 3,847,751 $0.00
Common Stock Series C Convertible Preferred Stock Disposition 2015-05-20 9,345,794 $0.00 2,336,448 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. Ms. Shupp is the CFO of Moral Compass Corporation. Moral Compass Corporation is owned by the John G. Sperling 2012 Irrevocable Trusts No. 1, 2 and 3. Ms. Shupp serves as one of three trustees of the Sperling trusts; these trustees share voting and investment power over the shares held by Moral Compass Corporation.
  2. The Series A Convertible Preferred Stock converted into the Issuer's common stock at a conversion ratio of one share of common stock for every four shares of preferred stock upon the closing of the Issuer's initial public offering of common stock, and had no expiration date. This conversion ratio reflected an adjustment due to the Issuer's 1-for-4 reverse stock split effected on May 8, 2015.
  3. The Series B Convertible Preferred Stock converted into the Issuer's common stock at a conversion ratio of one share of common stock for every four shares of preferred stock upon the closing of the Issuer's initial public offering of common stock, and had no expiration date. This conversion ratio reflected an adjustment due to the Issuer's 1-for-4 reverse stock split effected on May 8, 2015.
  4. The Series C Convertible Preferred Stock converted into the Issuer's common stock at a conversion ratio of one share of common stock for every four shares of preferred stock upon the closing of the Issuer's initial public offering of common stock, and had no expiration date. This conversion ratio reflected an adjustment due to the Issuer's 1-for-4 reverse stock split effected on May 8, 2015.